Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells

Cancer Research

Volumn 60, Issue 4, 2000, Pages 1028-1034

  Boczkowski, David ^a   Nair, Smita K ^a   Nam, Jong Hee ^a   Lyerly, H Kim ^a   Gilboa, Eli ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE AMPLIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; HUMANS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINATION;

EID: 0034652624     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Roth, C., Rochlitz, C., and Kourilsky, P. Immune response against tumors. Adv. Immunol., 57: 281-351, 1994.
2. Rosenberg, S. A., Kawakami, Y., Robbins, P. F., and Wang, R-F. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv. Cancer Res., 70: 145-177, 1996.
3. Boon, T., and van der Bruggen, P. Human tumor antigens recognised by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
4. Van den Eynde, B. J., and van der Bruggen. P. T cell defined tumor antigens. Curr. Opin. Immunol., 9: 684-693, 1997.
5. Anichini, A., Mortarini, R., Maccalli, C., Squarcina, P., Fleishhauer, K., Mascheroni, L., and Parmiani, G. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate KLA-A2.1-restricted immune repertoire to melanoma. J. Immunol., 156: 208-217, 1996.
6. Srivastava, P. K. Do human cancers express shared protective antigens? Or the necessity of remembrance of things past? Semin. Immunol., 8: 295-302, 1996.
7. Nair, S., Snyder, D., Rouse, B. T., and Gilboa, E. Regression of tumors in mice vaccinated with professional antigen presenting cells pulsed with tumor extracts. Int. J. Cancer, 70: 706-715, 1997.
8. Fields, R. C., Shimizu, K., and Mulθ, J. J. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci., 95: 9482-9487, 1998.
9. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183: 87-97, 1996.
10. Nair, S., Boczkowski, D., Snyder, D., and Gilboa. E. Antigen presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur. J. Immunol., 27: 589-597, 1997.
11. Tamura, Y., Peng, P., Liu, K., Daou, M., and Srivastava, P. K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (Washington DC), 278: 117-120, 1997.
12. Boczkowski, D., Nair, S. K., Snyder, D., and Gilboa, E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med., 184: 465-472, 1996.
13. Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D., and Gilboa, E. Bone marrow-generated dendritic cell pulsed with tumor extracts or tumor RNA induce anti-tumor immunity against central nervous system tumors. J. Exp. Med., 186: 1177-1182, 1997.
14. Kündig, T. M., Bachmann, M. F., Oehen, S., Hoffmann, U. W., Simard, J. J. L., Kalberer, C. P., Pircher, H., Ohashi, P. S., Hengartner, H., and Zinkernagel, R. M. On the role of antigen in maintaining cytotoxic T-cell memory. Proc. Natl. Acad. Sci. USA, 93: 9716-9723, 1996.
15. Matzinger, P. An innate sense of danger. Semin. Immunol., 10: 399-415, 1998.
16. Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., and Gilboa, E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat. Biotechnol., 16: 364-369, 1998.
17. Gilboa, E., Nair, S. K., and Lyerly, H. K. Immunotherapy of cancer with dendritic cell-based vaccines. Cancer Immunol. Immunother., 46: 82-87, 1998.
18. Porgador, A., Tzehoval, E., Vadai, E., Feldman, M., and Eisenbach, L. Combined vaccination with major histocompatibility class 1 and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Cancer Res., 55: 4941-4949, 1995.
19. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med., 176: 1693-1702, 1992.
20. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Frilsch, P. O., Steinman, R. M., and Schuler, G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180: 83-93, 1994.
21. Volgmann, T., Klein-Struckmeier, A., and Mohr, H. A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. J. Immunol. Methods, 119: 45-51, 1989.
22. Patel, P. H., and Preston, B. D. Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Proc. Natl. Acad. Sci. USA, 91: 549-553, 1994.
23. Peterson, L. A., Brown, M. R., Carlisle, A. J., Kohn, E. C., Liotta, L. A., Emmert-Buck, M. R., and Krizman, D. B. An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res., 58: 5326-5328, 1998.
24. Parmiani, G. Tumor immunity as autoimmunity: tumor antigens include normal self-proteins which stimulate anergic peripheral T cells. Immunol. Today, 14: 536-538, 1993.
25. Houghton, A. N. Cancer antigens: immune recognition of self and altered sell. J. Exp. Med., 180: 1-4, 1994.